<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25202012</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>289</Volume><Issue>43</Issue><PubDate><Year>2014</Year><Month>Oct</Month><Day>24</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>The LIMP-2/SCARB2 binding motif on acid &#x3b2;-glucosidase: basic and applied implications for Gaucher disease and associated neurodegenerative diseases.</ArticleTitle><Pagination><StartPage>30063</StartPage><EndPage>30074</EndPage><MedlinePgn>30063-74</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.593616</ELocationID><Abstract><AbstractText>The acid &#x3b2;-glucosidase (glucocerbrosidase (GCase)) binding sequence to LIMP-2 (lysosomal integral membrane protein 2), the receptor for intracellular GCase trafficking to the lysosome, has been identified. Heterologous expression of deletion constructs, the available GCase crystal structures, and binding and co-localization of identified peptides or mutant GCases were used to identify and characterize a highly conserved 11-amino acid sequence, DSPIIVDITKD, within human GCase. The binding to LIMP-2 is not dependent upon a single amino acid, but the interactions of GCase with LIMP-2 are heavily influenced by Asp(399) and the di-isoleucines, Ile(402) and Ile(403). A single alanine substitution at any of these decreases GCase binding to LIMP-2 and alters its pH-dependent binding as well as diminishing the trafficking of GCase to the lysosome and significantly increasing GCase secretion. Enterovirus 71 also binds to LIMP-2 (also known as SCARB2) on the external surface of the plasma membrane. However, the LIMP-2/SCARB2 binding sequences for enterovirus 71 and GCase are not similar, indicating that LIMP-2/SCARB2 may have multiple or overlapping binding sites with differing specificities. These findings have therapeutic implications for the production of GCase and the distribution of this enzyme that is delivered to various organs.</AbstractText><CopyrightInformation>&#xa9; 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liou</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>From the Division of Human Genetics, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haffey</LastName><ForeName>Wendy D</ForeName><Initials>WD</Initials><AffiliationInfo><Affiliation>the Department of Cancer Biology, Vontz Center for Molecular Studies, University of Cincinnati Medical Center, Cincinnati, Ohio 45229.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greis</LastName><ForeName>Kenneth D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>the Department of Cancer Biology, Vontz Center for Molecular Studies, University of Cincinnati Medical Center, Cincinnati, Ohio 45229.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grabowski</LastName><ForeName>Gregory A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>From the Division of Human Genetics, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229 and greg.grabowski@cchmc.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK036729</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DK 36729</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000588">Amines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosomal Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051116">Receptors, Scavenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C493330">Red DND-99</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074299">SCARB2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-22-9</RegistryNumber><NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.45</RegistryNumber><NameOfSubstance UI="D005962">Glucosylceramidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>OF5P57N2ZX</RegistryNumber><NameOfSubstance UI="D000409">Alanine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000588" MajorTopicYN="N">Amines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020816" MajorTopicYN="N">Amino Acid Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001667" MajorTopicYN="N">Binding, Competitive</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005776" MajorTopicYN="N">Gaucher Disease</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005962" MajorTopicYN="N">Glucosylceramidase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049452" MajorTopicYN="N">Green Fluorescent Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047468" MajorTopicYN="N">Immunoprecipitation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="N">Lysosomal Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016296" MajorTopicYN="N">Mutagenesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051116" MajorTopicYN="N">Receptors, Scavenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Enzyme Kinetics</Keyword><Keyword MajorTopicYN="N">Glucocerebrosidase</Keyword><Keyword MajorTopicYN="N">Inborn Error of Metabolism</Keyword><Keyword MajorTopicYN="N">Intracellular Trafficking</Keyword><Keyword MajorTopicYN="N">Lysosomal Storage Disease</Keyword><Keyword MajorTopicYN="N">Lysosomal Targeting</Keyword><Keyword MajorTopicYN="N">Protein Sorting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>10</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25202012</ArticleId><ArticleId IdType="pmc">PMC4208013</ArticleId><ArticleId IdType="doi">10.1074/jbc.M114.593616</ArticleId><ArticleId IdType="pii">S0021-9258(20)37338-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brady R. O., Kanfer J. N., Bradley R. M., Shapiro D. (1966) Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J. Clin. Invest. 45, 1112&#x2013;1115</Citation><ArticleIdList><ArticleId IdType="pmc">PMC292783</ArticleId><ArticleId IdType="pubmed">5338605</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady R. O., Kanfer J. N., Shapiro D. (1965) Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher's disease. Biochem. Biophys. Res. Commun. 18, 221&#x2013;225</Citation><ArticleIdList><ArticleId IdType="pubmed">14282020</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabowski G. A., Petsko G. A., Kolodny E. (2010) Gaucher disease. in The Metabolic and Molecular Bases of Inherited Disease (Valle D., Beaudet A. L., Vogelstein B., Kinzler K. W., Antonarakis S. E., Ballabio A., Sly W. S., eds) McGraw-Hill, New York</Citation></Reference><Reference><Citation>Grabowski G. A., Kolodny E. H., Weinreb N. J., Rosenbloom B. E., Prakash-Cheng A., Kaplan P., Charrow J., Pastores G. M., Mistry P. K. (2006) Gaucher disease: phenotypic and genetic variation. in The Metabolic and Molecular Bases of Inherited Diseases (Scriver C., Beaudet A., Sly W., Valle D., eds) McGraw-Hill, New York</Citation></Reference><Reference><Citation>Liou B., Kazimierczuk A., Zhang M., Scott C. R., Hegde R. S., Grabowski G. A. (2006) Analyses of variant acid &#x3b2;-glucosidases: effects of Gaucher disease mutations. J. Biol. Chem. 281, 4242&#x2013;4253</Citation><ArticleIdList><ArticleId IdType="pubmed">16293621</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorge J., West C., Westwood B., Beutler E. (1985) Molecular cloning and nucleotide sequence of the human glucocerebrosidase gene. Proc. Natl. Acad. Sci. U.S.A. 82, 7289&#x2013;7293</Citation><ArticleIdList><ArticleId IdType="pmc">PMC390835</ArticleId><ArticleId IdType="pubmed">3864160</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg-Fussman A., Grace M. E., Ioannou Y., Grabowski G. A. (1993) Human acid &#x3b2;-glucosidase: N-glycosylation site occupancy and the effect of glycosylation on enzymatic activity. J. Biol. Chem. 268, 14861&#x2013;14866</Citation><ArticleIdList><ArticleId IdType="pubmed">8325864</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornfeld S., Sly W. S. (2001) I-cell disease and pseudo-Hurler polydystrophy: disorders of lysosomal enzyme phosphorylation and localization. in The Metabolic and Molecular Bases of Inherited Disease (Scriver C. R., Beaudet A., Sly W., Valle D., eds) McGraw-Hill, New York</Citation></Reference><Reference><Citation>Reitman M. L., Kornfeld S. (1981) Lysosomal enzyme targeting: N-acetylglucosaminylphosphotransferase selectively phosphorylated native lysosomal enzymes. J. Biol. Chem. 256, 11977&#x2013;11980</Citation><ArticleIdList><ArticleId IdType="pubmed">6457829</ArticleId></ArticleIdList></Reference><Reference><Citation>Reczek D., Schwake M., Schr&#xf6;der J., Hughes H., Blanz J., Jin X., Brondyk W., Van Patten S., Edmunds T., Saftig P. (2007) LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of &#x3b2;-glucocerebrosidase. Cell 131, 770&#x2013;783</Citation><ArticleIdList><ArticleId IdType="pubmed">18022370</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonova T., Grabowski G. A. (2000) Fate and sorting of acid &#x3b2;-glucosidase in transgenic mammalian cells. Mol. Genet. Metab. 70, 281&#x2013;294</Citation><ArticleIdList><ArticleId IdType="pubmed">10993715</ArticleId></ArticleIdList></Reference><Reference><Citation>Saftig P., Schr&#xf6;der B., Blanz J. (2010) Lysosomal membrane proteins: life between acid and neutral conditions. Biochem. Soc. Trans. 38, 1420&#x2013;1423</Citation><ArticleIdList><ArticleId IdType="pubmed">21118100</ArticleId></ArticleIdList></Reference><Reference><Citation>Saftig P., Klumperman J. (2009) Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 10, 623&#x2013;635</Citation><ArticleIdList><ArticleId IdType="pubmed">19672277</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata S., Fukuda M. (1994) Lysosomal targeting of Limp II membrane glycoprotein requires a novel Leu-Ile motif at a particular position in its cytoplasmic tail. J. Biol. Chem. 269, 5210&#x2013;5217</Citation><ArticleIdList><ArticleId IdType="pubmed">8106503</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachos C., Blanz J., Saftig P., Schwake M. (2012) A critical histidine residue within LIMP-2 mediates pH sensitive binding to its ligand &#x3b2;-glucocerebrosidase. Traffic 13, 1113&#x2013;1123</Citation><ArticleIdList><ArticleId IdType="pubmed">22537104</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Peng W., Ren J., Hu Z., Xu J., Lou Z., Li X., Yin W., Shen X., Porta C., Walter T. S., Evans G., Axford D., Owen R., Rowlands D. J., Wang J., Stuart D. I., Fry E. E., Rao Z. (2012) A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 19, 424&#x2013;429</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Song Z., Qi Y., Feng X., Xu N., Sun Y., Wu X., Yao X., Mao Q., Li X., Dong W., Wan X., Huang N., Shen X., Liang Z., Li W. (2012) Molecular determinants of enterovirus 71 viral entry: cleft around Gln-172 on VP1 protein interacts with variable region on scavenge receptor B2. J. Biol. Chem. 287, 6406&#x2013;6420</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Koike S. (2011) Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J. Virol. 85, 4937&#x2013;4946</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. (2009) Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 15, 798&#x2013;801</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Knipper M., Claussen C., R&#xfc;ttiger L., Zimmermann U., L&#xfc;llmann-Rauch R., Eskelinen E. L., Schr&#xf6;der J., Schwake M., Saftig P. (2006) Deafness in LIMP2-deficient mice due to early loss of the potassium channel KCNQ1/KCNE1 in marginal cells of the stria vascularis. J. Physiol. 576, 73&#x2013;86</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1995639</ArticleId><ArticleId IdType="pubmed">16901941</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanz J., Groth J., Zachos C., Wehling C., Saftig P., Schwake M. (2010) Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand &#x3b2;-glucocerebrosidase. Hum. Mol. Genet. 19, 563&#x2013;572</Citation><ArticleIdList><ArticleId IdType="pubmed">19933215</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniwang E., Tayebi N., Sidransky E. (2013) Is Parkinson disease associated with lysosomal integral membrane protein type-2?: challenges in interpreting association data. Mol. Genet. Metab. 108, 269&#x2013;271</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3606890</ArticleId><ArticleId IdType="pubmed">23419877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez G., Sidransky E. (2013) Predicting parkinsonism: new opportunities from Gaucher disease. Mol. Genet. Metab. 109, 235&#x2013;236</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4141335</ArticleId><ArticleId IdType="pubmed">23665160</ArticleId></ArticleIdList></Reference><Reference><Citation>Westbroek W., Gustafson A. M., Sidransky E. (2011) Exploring the link between glucocerebrosidase mutations and parkinsonism. Trends Mol. Med. 17, 485&#x2013;493</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3351003</ArticleId><ArticleId IdType="pubmed">21723784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen V., Sardi S. P., Ng J., Xu Y. H., Sun Y., Tomlinson J. J., Kolodziej P., Kahn I., Saftig P., Woulfe J., Rochet J. C., Glicksman M. A., Cheng S. H., Grabowski G. A., Shihabuddin L. S., Schlossmacher M. G. (2011) Acid &#x3b2;-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter &#x3b1;-synuclein processing. Ann. Neurol. 69, 940&#x2013;953</Citation><ArticleIdList><ArticleId IdType="pubmed">21472771</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidransky E., Nalls M. A., Aasly J. O., Aharon-Peretz J., Annesi G., Barbosa E. R., Bar-Shira A., Berg D., Bras J., Brice A., Chen C. M., Clark L. N., Condroyer C., De Marco E. V., D&#xfc;rr A., Eblan M. J., Fahn S., Farrer M. J., Fung H. C., Gan-Or Z., Gasser T., Gershoni-Baruch R., Giladi N., Griffith A., Gurevich T., Januario C., Kropp P., Lang A. E., Lee-Chen G. J., Lesage S., Marder K., Mata I. F., Mirelman A., Mitsui J., Mizuta I., Nicoletti G., Oliveira C., Ottman R., Orr-Urtreger A., Pereira L. V., Quattrone A., Rogaeva E., Rolfs A., Rosenbaum H., Rozenberg R., Samii A., Samaddar T., Schulte C., Sharma M., Singleton A., Spitz M., Tan E. K., Tayebi N., Toda T., Troiano A. R., Tsuji S., Wittstock M., Wolfsberg T. G., Wu Y. R., Zabetian C. P., Zhao Y., Ziegler S. G. (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 361, 1651&#x2013;1661</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856322</ArticleId><ArticleId IdType="pubmed">19846850</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzulli J. R., Xu Y. H., Sun Y., Knight A. L., McLean P. J., Caldwell G. A., Sidransky E., Grabowski G. A., Krainc D. (2011) Gaucher disease glucocerebrosidase and &#x3b1;-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146, 37&#x2013;52</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3132082</ArticleId><ArticleId IdType="pubmed">21700325</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbro D., Grabowski G. A. (1991) Human acid &#x3b2;-glucosidase: use of inhibitory and activating monoclonal antibodies to investigate the enzyme's catalytic mechanism and saposin A and C binding sites. J. Biol. Chem. 266, 15021&#x2013;15027</Citation><ArticleIdList><ArticleId IdType="pubmed">1714449</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou B., Grabowski G. A. (2012) Is E326K glucocerebrosidase a polymorphic or pathological variant? Mol. Genet. Metab. 105, 528&#x2013;529</Citation><ArticleIdList><ArticleId IdType="pubmed">22227325</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar R. C. (2004) MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792&#x2013;1797</Citation><ArticleIdList><ArticleId IdType="pmc">PMC390337</ArticleId><ArticleId IdType="pubmed">15034147</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar R. C. (2004) MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 5, 113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC517706</ArticleId><ArticleId IdType="pubmed">15318951</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra S., Puertollano R., Kato Y., Bonifacino J. S., Hurley J. H. (2002) Structural basis for acidic-cluster-dileucine sorting-signal recognition by VHS domains. Nature 415, 933&#x2013;937</Citation><ArticleIdList><ArticleId IdType="pubmed">11859375</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough N. R., Zweifel M. E., Martinez-Augustin O., Aguilar R. C., Bonifacino J. S., Fambrough D. M. (1999) Utilization of the indirect lysosome targeting pathway by lysosome-associated membrane proteins (LAMPs) is influenced largely by the C-terminal residue of their GYXX&#x3c6; targeting signals. J. Cell Sci. 112, 4257&#x2013;4269</Citation><ArticleIdList><ArticleId IdType="pubmed">10564644</ArticleId></ArticleIdList></Reference><Reference><Citation>Barriocanal J. G., Bonifacino J. S., Yuan L., Sandoval I. V. (1986) Biosynthesis, glycosylation, movement through the Golgi system and transport to lysosomes by N-linked carbohydrate-independent mechanism of three lysosomal integral membrane proteins. J. Biol. Chem. 261, 16755&#x2013;16763</Citation><ArticleIdList><ArticleId IdType="pubmed">3782140</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullin N. P., Hitchen P. G., Taylor M. E. (1997) Mechanism of Ca2+ and monosaccharide binding to a C-type carbohydrate-recognition domain of the macrophage mannose receptor. J. Biol. Chem. 272, 5668&#x2013;5681</Citation><ArticleIdList><ArticleId IdType="pubmed">9038177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezekowitz R. A., Sastry K., Bailly P., Warner A. (1990) Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J. Exp. Med. 172, 1785&#x2013;1794</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2188777</ArticleId><ArticleId IdType="pubmed">2258707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornfeld S. (1992) Structure and function of the mannose 6-phosphate/insulin like growth factor II receptors. Annu. Rev. Biochem. 61, 307&#x2013;330</Citation><ArticleIdList><ArticleId IdType="pubmed">1323236</ArticleId></ArticleIdList></Reference><Reference><Citation>Velayati A., DePaolo J., Gupta N., Choi J. H., Moaven N., Westbroek W., Goker-Alpan O., Goldin E., Stubblefield B. K., Kolodny E., Tayebi N., Sidransky E. (2011) A mutation in SCARB2 is a modifier in Gaucher disease. Hum. Mutat. 32, 1232&#x2013;1238</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196787</ArticleId><ArticleId IdType="pubmed">21796727</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Qi X., Grabowski G. A. (2003) Saposin C is required for normal resistance of acid &#x3b2;-glucosidase to proteolytic degradation. J. Biol. Chem. 278, 31918&#x2013;31923</Citation><ArticleIdList><ArticleId IdType="pubmed">12813057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bultron G., Kacena K., Pearson D., Boxer M., Yang R., Sathe S., Pastores G., Mistry P. K. (2010) The risk of Parkinson's disease in type 1 Gaucher disease. J. Inherit. Metab. Dis. 33, 167&#x2013;173</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2887303</ArticleId><ArticleId IdType="pubmed">20177787</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardi S. P., Clarke J., Viel C., Chan M., Tamsett T. J., Treleaven C. M., Bu J., Sweet L., Passini M. A., Dodge J. C., Yu W. H., Sidman R. L., Cheng S. H., Shihabuddin L. S. (2013) Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. Proc. Natl. Acad. Sci. U.S.A. 110, 3537&#x2013;3542</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3587272</ArticleId><ArticleId IdType="pubmed">23297226</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardi S. P., Singh P., Cheng S. H., Shihabuddin L. S., Schlossmacher M. G. (2012) Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models. Neurodegener. Dis. 10, 195&#x2013;202</Citation><ArticleIdList><ArticleId IdType="pubmed">22327140</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardi S. P., Clarke J., Kinnecom C., Tamsett T. J., Li L., Stanek L. M., Passini M. A., Grabowski G. A., Schlossmacher M. G., Sidman R. L., Cheng S. H., Shihabuddin L. S. (2011) CNS expression of glucocerebrosidase corrects &#x3b1;-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc. Natl. Acad. Sci. U.S.A. 108, 12101&#x2013;12106</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3141921</ArticleId><ArticleId IdType="pubmed">21730160</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Ren J., Padilla-Parra S., Fry E. E., Stuart D. I. (2014) Lysosomal sorting of &#x3b2;-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor. Nat. Commun. 5, 4321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4104448</ArticleId><ArticleId IdType="pubmed">25027712</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>